Saturday, March 20, 2010: 4:00 PM-6:00 PM
Regency VI-VII (Hyatt Regency Atlanta)
CME Credits: 2
Summary: MDR-GNR have become a major challenge in healthcare facilities around the world. Though regional differences exist among the types of pathogens and resistance patterns that are of most concern, there is a common belief that these pathogens pose a growing threat to patient safety. This symposium will review the changing, worldwide epidemiology of MDR-GNR over the past decade and set the current stage of this problem. Other speakers will then discuss optimal infection control approaches to MDR-GNR and describe the gaps in our current knowledge of MDR control and issues surrounding new drug development for MDR-GNR.Learning Objectives:
- Describe the changes in the epidemiology of MDR-GNR over the past decade.
- Describe current understanding of optimal infection control efforts for MDR-GNR and identify the knowledge gaps.
- List challenges and opportunities in the development of antimicrobials to treat MDR-GNR.
David Calfee, MD and Anna-Pelagia Magiorakos, MD